BML Investment Partners L.P. 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-21 10:12 am Purchase |
2024-05-21 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
BML Investment Partners L.P. | 369,296 11.000% |
199,873 (+117.97%) |
Filing |
| 2024-01-16 5:54 pm Purchase |
2024-01-10 | 13G | Reneo Pharmaceuticals, Inc. RPHM |
BML Investment Partners L.P. | 169,423 5.100% |
169,423 (New Position) |
Filing |